Atherosclerosis

Aims & Scope

Atherosclerosis has an open access mirror journal Atherosclerosis: X, sharing the same aims and scope, editorial team, submission system and rigorous peer review.

Atherosclerosis brings together, from all sources, papers concerned with investigation on atherosclerosis, its risk factors and clinical manifestations.

Atherosclerosis covers basic and translational, clinical and population research approaches to arterial and vascular biology and disease, as well as their risk factors including: disturbances of lipid and lipoprotein metabolism, diabetes and hypertension, thrombosis, and inflammation.

The Editors are interested in original or review papers dealing with the pathogenesis, environmental, genetic and epigenetic basis, diagnosis or treatment of atherosclerosis and related diseases as well as their risk factors.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	5.7
2024	4.90

SJR (SCImago Journal Rank)

Year	Value
2024	1.762

Quartile

Year	Value
2024	Q1

Journal Rank

Year	Value
2024	1794

Journal Citation Indicator

Year	Value
2024	3623

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?

  Citation: 1371

  Authors: John S, Meena, Steve E, Vidya

• Adhesion molecules and atherosclerosis

  Citation: 810

  Authors: Stefan, Sandrine, Laurence

• 2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk

  Citation: 803

  Authors: François, Colin, Alberico L., Konstantinos C., Manuela, Lina, M. John, Guy G., Victoria, Brian A., Ian M., Alison, Ulf, Borislava, Terje R., Gabriele, Dimitrios J., Marc S., Marja-Riitta, Lale, Olov, Stephan, Victor, Colin, Jean-Philippe, Veronica, Victoria, Donna, Chris P., Diederick, Sigrun, Gerhard, Bernard, Peter, Hugo A., Ulf, Christophe, Maddalena, Basil S., Bela, Christian, Steffen, Anna Sonia, Dimitrios J., Marco, Evgeny, Iain A., Miguel, Rhian M., Djamaleddine, Parounak H., Peter, Ruslan, Philippe, Belma, Arman, Lambros, Jindřich, Mogens Lytken, Hesham Salah, Margus, Timo E., Jean, Rusudan, Ulrich, Loukianos, László, Thorbjörn, Vincent, Yaakov, Michele Massimo, Aisulu, Gani, Alina, Gustavs, Omar, Rimvydas, Laurent, Philip, Victoria, Aneta, Mbarek, Frank, Irena, Kjetil, Piotr, Ricardo, Dan, Marat, Marina, Vojislav, Daniel, Zlatko, Leopoldo, Emil, Roger, Leila, Oner, Olena, Riyaz S.

• Quantitative assessment of atherosclerotic lesions in mice

  Citation: 764

  Authors: Beverly, Arlene, Patricia A., Diane, Roger A.

• Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines

  Citation: 760

  Authors: Johan, Ann-Kristin, Pernilla, Ulf, Jesper, Ulf, Göran K.

• Conjugated linoleic acid and atherosclerosis in rabbits

  Citation: 759

  Authors: Kisun N., David, Michael W.

• Oxysterols and atherosclerosis

  Citation: 749

  Authors: Andrew J, Wendy

• High prevalence of peripheral arterial disease and co-morbidity in 6880 primary care patients: cross-sectional study

  Citation: 643

  Authors: Curt, Alexander, Jens R., Harald, Roman, Stefan, David, Berndt, Gerhart, Hans-Joachim

• The role of vascular biomarkers for primary and secondary prevention. A position paper from the European Society of Cardiology Working Group on peripheral circulation

  Citation: 634

  Authors: Charalambos, Panagiotis, Victor, Marianne, Renata, Francesco, Marco, Augusto, Ulf, Stéphane, John, Dimitri P., Katerina K., Athanasios D., Damiano, Arno, Luc, Thomas, Akira, Reuven, Pierre, John, Michael, Jeong Bae, Giuseppe, Henrik, Raymond R.

• Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase

  Citation: 606

  Authors: M, S, C, P

---